COVID-19 Impact on Global Blood Pressure Disorders Drug Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Blood Pressure Disorders Drug Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Diuretics
  • 1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
  • 1.4.4 Angiotensin Receptor Blockers (ARBs)
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Blood Pressure Disorders Drug Market Share by Application: 2020 VS 2026
  • 1.5.2 Hypertension
  • 1.5.3 Hypotension
  • 1.5.4 Pulmonary Hypertension
• 1.6 Coronavirus Disease 2019 (Covid-19): Blood Pressure Disorders Drug Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Blood Pressure Disorders Drug Industry
    • 1.6.1.1 Blood Pressure Disorders Drug Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Blood Pressure Disorders Drug Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Blood Pressure Disorders Drug Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Blood Pressure Disorders Drug Market Perspective (2015-2026)
• 2.2 Blood Pressure Disorders Drug Growth Trends by Regions
  • 2.2.1 Blood Pressure Disorders Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Blood Pressure Disorders Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Blood Pressure Disorders Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Blood Pressure Disorders Drug Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Blood Pressure Disorders Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Blood Pressure Disorders Drug Players by Market Size
  • 3.1.1 Global Top Blood Pressure Disorders Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Blood Pressure Disorders Drug Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Blood Pressure Disorders Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Blood Pressure Disorders Drug Market Concentration Ratio
  • 3.2.1 Global Blood Pressure Disorders Drug Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Blood Pressure Disorders Drug Revenue in 2019
• 3.3 Blood Pressure Disorders Drug Key Players Head office and Area Served
• 3.4 Key Players Blood Pressure Disorders Drug Product Solution and Service
• 3.5 Date of Enter into Blood Pressure Disorders Drug Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Blood Pressure Disorders Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2021-2026)

5 Blood Pressure Disorders Drug Breakdown Data by Application (2015-2026)

• 5.1 Global Blood Pressure Disorders Drug Market Size by Application (2015-2020)
• 5.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Blood Pressure Disorders Drug Market Size (2015-2020)
• 6.2 Blood Pressure Disorders Drug Key Players in North America (2019-2020)
• 6.3 North America Blood Pressure Disorders Drug Market Size by Type (2015-2020)
• 6.4 North America Blood Pressure Disorders Drug Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Blood Pressure Disorders Drug Market Size (2015-2020)
• 7.2 Blood Pressure Disorders Drug Key Players in Europe (2019-2020)
• 7.3 Europe Blood Pressure Disorders Drug Market Size by Type (2015-2020)
• 7.4 Europe Blood Pressure Disorders Drug Market Size by Application (2015-2020)

8 China

• 8.1 China Blood Pressure Disorders Drug Market Size (2015-2020)
• 8.2 Blood Pressure Disorders Drug Key Players in China (2019-2020)
• 8.3 China Blood Pressure Disorders Drug Market Size by Type (2015-2020)
• 8.4 China Blood Pressure Disorders Drug Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Blood Pressure Disorders Drug Market Size (2015-2020)
• 9.2 Blood Pressure Disorders Drug Key Players in Japan (2019-2020)
• 9.3 Japan Blood Pressure Disorders Drug Market Size by Type (2015-2020)
• 9.4 Japan Blood Pressure Disorders Drug Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Blood Pressure Disorders Drug Market Size (2015-2020)
• 10.2 Blood Pressure Disorders Drug Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Blood Pressure Disorders Drug Market Size by Type (2015-2020)
• 10.4 Southeast Asia Blood Pressure Disorders Drug Market Size by Application (2015-2020)

11 India

• 11.1 India Blood Pressure Disorders Drug Market Size (2015-2020)
• 11.2 Blood Pressure Disorders Drug Key Players in India (2019-2020)
• 11.3 India Blood Pressure Disorders Drug Market Size by Type (2015-2020)
• 11.4 India Blood Pressure Disorders Drug Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Blood Pressure Disorders Drug Market Size (2015-2020)
• 12.2 Blood Pressure Disorders Drug Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Blood Pressure Disorders Drug Market Size by Type (2015-2020)
• 12.4 Central & South America Blood Pressure Disorders Drug Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 A1M Pharma AB
  • 13.1.1 A1M Pharma AB Company Details
  • 13.1.2 A1M Pharma AB Business Overview and Its Total Revenue
  • 13.1.3 A1M Pharma AB Blood Pressure Disorders Drug Introduction
  • 13.1.4 A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2015-2020))
  • 13.1.5 A1M Pharma AB Recent Development
• 13.2 Acceleron Pharma Inc
  • 13.2.1 Acceleron Pharma Inc Company Details
  • 13.2.2 Acceleron Pharma Inc Business Overview and Its Total Revenue
  • 13.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Introduction
  • 13.2.4 Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.2.5 Acceleron Pharma Inc Recent Development
• 13.3 Ache Laboratorios Farmaceuticos SA
  • 13.3.1 Ache Laboratorios Farmaceuticos SA Company Details
  • 13.3.2 Ache Laboratorios Farmaceuticos SA Business Overview and Its Total Revenue
  • 13.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Introduction
  • 13.3.4 Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.3.5 Ache Laboratorios Farmaceuticos SA Recent Development
• 13.4 Actelion Pharmaceuticals Ltd
  • 13.4.1 Actelion Pharmaceuticals Ltd Company Details
  • 13.4.2 Actelion Pharmaceuticals Ltd Business Overview and Its Total Revenue
  • 13.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Introduction
  • 13.4.4 Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.4.5 Actelion Pharmaceuticals Ltd Recent Development
• 13.5 Aerogen Ltd
  • 13.5.1 Aerogen Ltd Company Details
  • 13.5.2 Aerogen Ltd Business Overview and Its Total Revenue
  • 13.5.3 Aerogen Ltd Blood Pressure Disorders Drug Introduction
  • 13.5.4 Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.5.5 Aerogen Ltd Recent Development
• 13.6 Anavex Life Sciences Corp
  • 13.6.1 Anavex Life Sciences Corp Company Details
  • 13.6.2 Anavex Life Sciences Corp Business Overview and Its Total Revenue
  • 13.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Introduction
  • 13.6.4 Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.6.5 Anavex Life Sciences Corp Recent Development
• 13.7 AnGes Inc
  • 13.7.1 AnGes Inc Company Details
  • 13.7.2 AnGes Inc Business Overview and Its Total Revenue
  • 13.7.3 AnGes Inc Blood Pressure Disorders Drug Introduction
  • 13.7.4 AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.7.5 AnGes Inc Recent Development
• 13.8 Arena Pharmaceuticals Inc
  • 13.8.1 Arena Pharmaceuticals Inc Company Details
  • 13.8.2 Arena Pharmaceuticals Inc Business Overview and Its Total Revenue
  • 13.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
  • 13.8.4 Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.8.5 Arena Pharmaceuticals Inc Recent Development
• 13.9 Ascendia Pharmaceuticals LLC
  • 13.9.1 Ascendia Pharmaceuticals LLC Company Details
  • 13.9.2 Ascendia Pharmaceuticals LLC Business Overview and Its Total Revenue
  • 13.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Introduction
  • 13.9.4 Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.9.5 Ascendia Pharmaceuticals LLC Recent Development
• 13.10 Ascendis Pharma A/S
  • 13.10.1 Ascendis Pharma A/S Company Details
  • 13.10.2 Ascendis Pharma A/S Business Overview and Its Total Revenue
  • 13.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Introduction
  • 13.10.4 Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 13.10.5 Ascendis Pharma A/S Recent Development
• 13.11 AVEO Pharmaceuticals Inc
  • 10.11.1 AVEO Pharmaceuticals Inc Company Details
  • 10.11.2 AVEO Pharmaceuticals Inc Business Overview and Its Total Revenue
  • 10.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
  • 10.11.4 AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.11.5 AVEO Pharmaceuticals Inc Recent Development
• 13.12 Bayer AG
  • 10.12.1 Bayer AG Company Details
  • 10.12.2 Bayer AG Business Overview and Its Total Revenue
  • 10.12.3 Bayer AG Blood Pressure Disorders Drug Introduction
  • 10.12.4 Bayer AG Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.12.5 Bayer AG Recent Development
• 13.13 Bial - Portela & Ca SA
  • 10.13.1 Bial - Portela & Ca SA Company Details
  • 10.13.2 Bial - Portela & Ca SA Business Overview and Its Total Revenue
  • 10.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Introduction
  • 10.13.4 Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.13.5 Bial - Portela & Ca SA Recent Development
• 13.14 Bioblue Technologies Inc
  • 10.14.1 Bioblue Technologies Inc Company Details
  • 10.14.2 Bioblue Technologies Inc Business Overview and Its Total Revenue
  • 10.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Introduction
  • 10.14.4 Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.14.5 Bioblue Technologies Inc Recent Development
• 13.15 Biogen Inc
  • 10.15.1 Biogen Inc Company Details
  • 10.15.2 Biogen Inc Business Overview and Its Total Revenue
  • 10.15.3 Biogen Inc Blood Pressure Disorders Drug Introduction
  • 10.15.4 Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.15.5 Biogen Inc Recent Development
• 13.16 Biolab Farmaceutica Ltda
  • 10.16.1 Biolab Farmaceutica Ltda Company Details
  • 10.16.2 Biolab Farmaceutica Ltda Business Overview and Its Total Revenue
  • 10.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Introduction
  • 10.16.4 Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.16.5 Biolab Farmaceutica Ltda Recent Development
• 13.17 BioRestorative Therapies Inc
  • 10.17.1 BioRestorative Therapies Inc Company Details
  • 10.17.2 BioRestorative Therapies Inc Business Overview and Its Total Revenue
  • 10.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Introduction
  • 10.17.4 BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.17.5 BioRestorative Therapies Inc Recent Development
• 13.18 Boryung Pharmaceutical Co Ltd
  • 10.18.1 Boryung Pharmaceutical Co Ltd Company Details
  • 10.18.2 Boryung Pharmaceutical Co Ltd Business Overview and Its Total Revenue
  • 10.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
  • 10.18.4 Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.18.5 Boryung Pharmaceutical Co Ltd Recent Development
• 13.19 Bristol-Myers Squibb Co
  • 10.19.1 Bristol-Myers Squibb Co Company Details
  • 10.19.2 Bristol-Myers Squibb Co Business Overview and Its Total Revenue
  • 10.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Introduction
  • 10.19.4 Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.19.5 Bristol-Myers Squibb Co Recent Development
• 13.20 Camurus AB
  • 10.20.1 Camurus AB Company Details
  • 10.20.2 Camurus AB Business Overview and Its Total Revenue
  • 10.20.3 Camurus AB Blood Pressure Disorders Drug Introduction
  • 10.20.4 Camurus AB Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.20.5 Camurus AB Recent Development
• 13.21 Capricor Therapeutics Inc
  • 10.21.1 Capricor Therapeutics Inc Company Details
  • 10.21.2 Capricor Therapeutics Inc Business Overview and Its Total Revenue
  • 10.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Introduction
  • 10.21.4 Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.21.5 Capricor Therapeutics Inc Recent Development
• 13.22 Celsion Corp
  • 10.22.1 Celsion Corp Company Details
  • 10.22.2 Celsion Corp Business Overview and Its Total Revenue
  • 10.22.3 Celsion Corp Blood Pressure Disorders Drug Introduction
  • 10.22.4 Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.22.5 Celsion Corp Recent Development
• 13.23 Celtaxsys Inc
  • 10.23.1 Celtaxsys Inc Company Details
  • 10.23.2 Celtaxsys Inc Business Overview and Its Total Revenue
  • 10.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Introduction
  • 10.23.4 Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.23.5 Celtaxsys Inc Recent Development
• 13.24 Chiesi Farmaceutici SpA
  • 10.24.1 Chiesi Farmaceutici SpA Company Details
  • 10.24.2 Chiesi Farmaceutici SpA Business Overview and Its Total Revenue
  • 10.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Introduction
  • 10.24.4 Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.24.5 Chiesi Farmaceutici SpA Recent Development
• 13.25 Chong Kun Dang Pharmaceutical Corp
  • 10.25.1 Chong Kun Dang Pharmaceutical Corp Company Details
  • 10.25.2 Chong Kun Dang Pharmaceutical Corp Business Overview and Its Total Revenue
  • 10.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Introduction
  • 10.25.4 Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.25.5 Chong Kun Dang Pharmaceutical Corp Recent Development
• 13.26 Chugai Pharmaceutical Co Ltd
  • 10.26.1 Chugai Pharmaceutical Co Ltd Company Details
  • 10.26.2 Chugai Pharmaceutical Co Ltd Business Overview and Its Total Revenue
  • 10.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
  • 10.26.4 Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.26.5 Chugai Pharmaceutical Co Ltd Recent Development
• 13.27 CJ HealthCare Corp
  • 10.27.1 CJ HealthCare Corp Company Details
  • 10.27.2 CJ HealthCare Corp Business Overview and Its Total Revenue
  • 10.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Introduction
  • 10.27.4 CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.27.5 CJ HealthCare Corp Recent Development
• 13.28 Complexa Inc
  • 10.28.1 Complexa Inc Company Details
  • 10.28.2 Complexa Inc Business Overview and Its Total Revenue
  • 10.28.3 Complexa Inc Blood Pressure Disorders Drug Introduction
  • 10.28.4 Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.28.5 Complexa Inc Recent Development
• 13.29 Corion Biotech Srl
  • 10.29.1 Corion Biotech Srl Company Details
  • 10.29.2 Corion Biotech Srl Business Overview and Its Total Revenue
  • 10.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Introduction
  • 10.29.4 Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2015-2020)
  • 10.29.5 Corion Biotech Srl Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer